page-loading-spinner
Home Is the medicine worse than the illness?

Is the medicine worse than the illness?

The User's Profile Chris Martenson December 27, 2008
1
placeholder image
Saturday, December 27, 2008

In this report, I explore a remarkable article by Mr. James Grant that appeared in the December 20th edition of the Wall Street Journal.  This article is remarkable because Grant correctly identifies the Fed as the source of current economic troubles and makes the case that, under a gold standard, we might have a different set of troubles, but we wouldn’t be facing an extinction-level event for finance.  With the deft use of historical examples, he makes a strong case that our current ills stem from very common mistakes that have plagued central banking ever since it was first invented.  I expand on several of his arguments to steer towards the conclusion that inflation lies in wait.

James Grant writes The Interest Rate Observer, a financial newsletter with an $850/yr subscription price. If you are not impressed by high numbers, then you might care that James Grant has been in the business a long time and has been especially good about providing a conflict-of-interest-free newsletter since 1983.

I always enjoy his commentary and consider him to be one of the best in the business.

Imagine my surprise to see him openly discussing the abolishment of the Fed in a Wall Street Journal editorial last week. And extolling the virtues of a gold standard. You could have knocked me off my stool with a feather.

This article is a MUST READ. In fact, I think everyone should read it twice over and then leave it in the bathroom for further contemplation until all the finer points sink in.

Is the Medicine Worse Than the Illness?

The world ran out of trust in 2008 — but there is no shortage of money because the Fed is printing like mad. It’s the wrong approach, with potentially dire consequences, says James Grant.

It is a sorry place at which we Americans find ourselves this none-too-festive holiday season. The biggest names on Wall Street have gone to their rewards or into partnership with the U.S. Treasury. Foreigners stare wide-eyed from across the waters. A $50 billion Ponzi scheme (baited with, of all things in this age of excess, the promise of low, spuriously predictable returns)? Interest rates over which tiny Japanese rates fairly tower? Regulatory policy seemingly set by a weather vane?

The rest is exclusive content for members

Curious about what being a member offers? Sign up now for a risk-free trial and get a sneak peek into the premium content, features, and perks awaiting you on the other side.